Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics

Journal of Stroke and Cerebrovascular Diseases

Volumn 27, Issue 1, 2018, Pages 246-256

  Behrouz, Réza ^a   Masjuán Vallejo, Jaime ^b   Vera, Rocío ^b   Willey, Joshua Z ^c   Zedet, Mickael ^d   Moulin, Solène ^d   Cordonnier, Charlotte ^d   Klijn, Catharina J M ^e   Kanselaar, Karin ^e   Dirks, Maaike ^f   Silver, Brian ^g   Khan, Muhib ^h   Azarpazhooh, Mahmoud R ^i,j   Godoy, Daniel A ^k   Roffe, Christine ^l   Paley, Lizz ^m   Bray, Benjamin D ⁿ   Smith, Craig J ^o,p   Di Napoli, Mario ^q,r  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c Columbia University College of Physician and Surgeons ^*  (United States)

^d CHU Lille   (France)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h SPECTRUM HEALTH   (United States)

ⁱ WESTERN UNIVERSITY   (Canada)

^j MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^k Neurocritical Care Unit Sanatorio Pasteur   (Argentina)

^l KEELE UNIVERSITY   (United Kingdom)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ KING'S COLLEGE LONDON   (United Kingdom)

^o SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^p UNIVERSITY OF MANCHESTER   (United Kingdom)

^q SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^r The Neurological Section   (Italy)

more..

Author keywords

acute stroke; Acute stroke treatment; elderly; nonagenarian; thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL OUTCOME; CONTROLLED STUDY; DISABILITY; FEMALE; FUNCTIONAL STATUS; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RANKIN SCALE; REGISTER; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; AGE; ARGENTINA; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; CLINICAL DECISION MAKING; CLINICAL TRIAL; EUROPE; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NORTH AMERICA; ODDS RATIO; PATHOPHYSIOLOGY; PATIENT SELECTION; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

AGE FACTORS; AGED, 80 AND OVER; ARGENTINA; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; CLINICAL DECISION-MAKING; DISABILITY EVALUATION; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NORTH AMERICA; ODDS RATIO; PATIENT SELECTION; REGISTRIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 85029545883     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2017.08.031     Document Type: Article

References (34)

1. United States Census Bureau, An aging world: 2015; International population reports. Available at: https://www.census.gov/content/dam/Census/library/publications/2016/demo/p95-16-1.pdf. (Accessed 16 May 2016)
2. United States Census Bureau, Comprehensive analysis of fast-growing 90-and-older population. Available at: https://www.census.gov/newsroom/releases/archives/aging_population/cb11-194.html. (Accessed 16 May 2016)
3. Saposnik, G., Black, S., Stroke in the very elderly: hospital care, case fatality and disposition. Cerebrovas Dis 27 (2009), 537–543.
4. Bray, B.D., Campbell, J., Hoffman, A., et al. Stroke thrombolysis in England: an age stratified analysis of practice and outcome. Age Ageing 42 (2013), 240–245.
5. Derex, L., Nighoghossian, N., Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol 5 (2009), 506–511.
6. Chen, R.L., Balami, J.S., Esiri, M.M., et al. Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol 6 (2010), 2562–2565.
7. Russo, T., Felzani, G., Marini, C., Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use. J Aging Res, 2011, 2011, 108785.
8. Arora, R., Salamon, E., Katz, J.M., et al. Use and outcomes of intravenous thrombolysis for acute ischemic stroke in patients ≥90 years of age. Stroke 47 (2016), 2347–2354.
9. Mutgi, S.A., Behrouz, R., Practice diversity among US stroke physicians with respect to the 3- to 4.5-h window. Int J Stroke 10 (2015), E24–E25.
10. Mateen, F.J., Buchan, A.M., Hill, M.D., Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians. Stroke 41 (2010), 1833–1835.
11. Mateen, F.J., Nasser, M., Spencer, B.R., et al. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc 84 (2009), 334–338.
12. Sun, M.C., Lai, T.B., Jeng, J.S., et al. Safety of intravenous thrombolysis for ischaemic stroke in Asian octogenarians and nonagenarians. Age Ageing 44 (2015), 158–161.
13. Sarikaya, H., Arnold, M., Engelter, S.T., et al. Intravenous thrombolysis in nonagenarians with ischemic stroke. Stroke 42 (2011), 1967–1970.
14. Ford, G.A., Ahmed, N., Azevedo, E., et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke 41 (2010), 2568–2574.
15. Mishra, N.K., Ahmed, N., Andersen, G., et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ, 341, 2010, c6046.
16. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995), 1581–1587.
17. Sandercock, P., Wardlaw, J.M., Lindley, R.I., et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet 379 (2012), 2352–2363.
18. IST Collaborative Group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the Third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol 12 (2013), 768–776.
19. WHO MONICA Project Principal Investigators, The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41 (1988), 105–114.
20. Wahlgren, N., Ahmed, N., Davalos, A., et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369 (2007), 275–282.
21. King, G., Honaker, J., Joseph, A., et al. Analyzing incomplete political science data: an alternative algorithm for multiple imputation. Am Polit Sci Rev 95 (2001), 49–69.
22. Rubin, D.B., Multiple imputation for nonresponse in surveys. 1987, John Wiley & Sons, New York.
23. Rubin, D.B., The use of matched sampling and regression adjustment to remove bias in observational studies. Biometrics 29 (1973), 185–203.
24. Iacus, S.M., King, G., Porro, G., Causal inference without balance checking: Coarsened exact matching. [published online ahead of print August 23, 2011]. Political Analysis; Available at: http://pan.oxfordjournals.org/content/20/1/1.full, 2011. (Accessed 25 April 2017)
25. Rubin, D.B., Thomas, N., Combining propensity score matching with additional adjustments for prognostic covariates. J Am Stat Assoc 95 (2000), 573–585.
26. Ho, D., Imai, K., King, G., et al. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal 15 (2007), 199–236.
27. The European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee, Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25 (2008), 457–507.
28. Powers, W.J., Derdeyn, C.P., Biller, J., et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46 (2015), 3020–3035.
29. Bateman, B.T., Schumacher, H.C., Boden-Albala, B., et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke 37 (2006), 440–446.
30. Fonarow, G.C., Reeves, M.J., Zhao, X., et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation 121 (2010), 879–891.
31. Benjamin, E.J., Wolf, P.A., D'Agostino, R.B., et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998), 946–952.
32. Murphy, A., Symons, S.P., Hopyan, J., et al. Factors influencing clinically meaningful recanalization after IV-rtPA in acute ischemic stroke. AJNR Am J Neuroradiol 34 (2013), 146–152.
33. Khan, M.A., Baird, G.L., Miller, D., et al. Endovascular treatment of acute ischemic stroke in nonagenarians compared with younger patients in a multicenter cohort. J Neurointerv Surg, 2016, 10.1136/neurintsurg-2016-012427.
34. Weimar, C., Konig, I.R., Kraywinkel, K., et al. Age and National Institutes of Health Stroke Scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia. Development and external validation of prognostic models. Stroke 35 (2004), 158–162.